(Q28198658)

1

0 references

Emily B Zadvorny

2

0 references

Margaret A Cording

3

0 references

Ryan T Suemoto

4

0 references

Jilian Skog

5

0 references

Amir Harari

American Journal of Health-System Pharmacy

6

0 references

language of work or name

English

0 references

publication date

15 July 2006

0 references

published in

0 references

volume

63

0 references

issue

14

0 references

page(s)

1325-31

0 references

cites work

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Economic costs of diabetes in the US in 2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Effect of improved glycemic control on health care costs and utilization

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Standards of medical care in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430

Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050430